GlassScriptPhysician profile
David H Robbins
NPI 1124003090
$8,805.43
in general payments reported to CMS, 2019-2025
27 companies · $480 in 2025
The $480 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,660 · 2020: $426 · 2021: $5,000 · 2022: $258 · 2023: $251 · 2024: $731 · 2025: $480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,289 · Travel and Lodging: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,288.59 |
| Travel and Lodging | $172.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medivators INC. | $3,750.00 | 2021 | |
| Boston Scientific Corporation | $641.28 | 2019-2025 | Exalt Model D, Ams 700, Acquire |
| E.R. Squibb & Sons, L.L.C. | $610.61 | 2021 | |
| Pentax of America, INC. | $519.24 | 2023-2025 | Pentax Medical, Inspira, C2 Cryoballoon |
| Fujifilm Healthcare Americas Corporation | $452.35 | 2019-2022 | |
| Micro-Tech Endoscopy USA, INC. | $352.31 | 2019-2023 | Endorotor |
| Allergan, INC. | $346.67 | 2019-2020 | |
| Medtronic, INC. | $269.45 | 2021-2025 | Pillcam |
| Olympus America INC. | $268.37 | 2019-2021 | |
| Qol Medical, LLC | $236.51 | 2019-2021 | |
| Abbvie INC. | $219.13 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $199.08 | 2019-2023 | Dificid |
| Lucid Diagnostics INC. | $157.19 | 2021 | |
| Madrigal Pharmaceuticals | $140.74 | 2025 | Rezdiffra |
| Ethicon US, LLC | $124.99 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $121.30 | 2019 | |
| Ironwood Pharmaceuticals, INC | $94.96 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $80.71 | 2019 | |
| Pfizer INC. | $52.08 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $30.01 | 2025 | Iqirvo |
| Nestle Healthcare Nutrition INC. | $26.15 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $24.85 | 2022 | |
| Celgene Corporation | $24.03 | 2022 | |
| Endogastric Solutions, INC | $23.78 | 2019 | |
| Gilead Sciences, INC. | $14.47 | 2019 | |
| Axogen | $13.98 | 2023 | Avance Nerve Graft |
| Amarin Pharma, INC. | $11.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Robbins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.